DENVER–(BUSINESS WIRE)– Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts.
Cannabis Science has been working closely with this patient who has multiple squamous cell carcinoma tumors on his head. The latest pictures indicate that this patient is making dramatic improvement using cannabis-extract topical therapy under scientific guidance from Cannabis Science.
In this pictorial sequence, you can see the tumors healing, and scabbing over. The holes, like a “bowling ball finger hole”, are now filled and scabbing over as healing appears to continue. In another set of images, tumor mass continues to degrade. The patient has also informed Cannabis Science that while using cannabis extracts he has had a sufficient reduction in pain as healing progresses.
Position A: The arrow in Figure 1 points to what was the “bowling ball finger hole” that went down to the skull and was obvious prior to any type treatment. Figure A2 shows that in just the few days since our last update, the scabbed over hole has filled in and is almost totally healed. This lesion is now totally pain free.
Position B: The arrow in Figure B1, B2, and B3 point to an orientation position. These three sequential photographs show the tumor receding from this point as tumor mass continues to degrade. A doctor who felt this tumor commented that it appears to be detached and ready to fall off. Friends and family are amazed at the rapid progress.
Position C: This tumor, after becoming open and bloody in photo 2, is now scabbed over and pain free in photo 3.
Cannabis Science works closely with numerous patients who are suffering from a variety of illnesses and self-treating their illnesses with cannabis extracts. With its global impact on so many people and often-poor treatment outcomes for patients, we have focused on cannabis extract-based treatment options for cancer. Cannabis Science has provided the scientific foundation for numerous patients suffering from cancer to make the informed decision to treat themselves with cannabis extracts.
You can view these graphic photos on the Cannabis Science website www.cannabisscience.com and click the button “View Images of 3rd Self-Medicated Patient & His Apparent Success”.
Click here to view the images
You can read more news on this 3rd patient as well on the Cannabis Science website www.cannabisscience.com and click on the breaking news button where you will find all the cancer related and updated patient news.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
Robert Kane, 1-561-234-6929
Investor Relations Management